Revises the CA single-state Medicaid Supplemental Drug Rebate Agreements, that is the Medi-Cal Average Manufacturer Price Supplemental Drug Rebate Agreement and the Medi-Cal Net Cost Supplemental Drug Rebate Agreement, to give the state the ability to collect state supplemental drug rabates from manufacturers for managed care populations.